-
Trending: Blending, The Fad for Mixing Public, Charitable and Private Money
MEETING the United Nations’ Sustainable Development Goals will require additional investments of $2.5 trillion a year in things like health care and education for the world’s poorest people, according to UNCTAD, a UN agency. A further $13.5 trillion is needed by 2030 to implement the Paris climate accord, according to the International Energy Agency, a watchdog group. It is enough to drive development types to drink—which may be how they came up with the term “blended finance”, a heady cocktail of public, private and charitable money.
- Categories
- Uncategorized
- Region
- South Asia
-
No Radiotherapy, No MRI, No Money: Uganda’s Health Funding Crisis
Monday 11 April was not a normal day in the radiotherapy clinic at the Mulago National Referral hospital in Kampala.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Viewpoint: Review Moratorium on Oil Palm Plantations
President Joko “Jokowi” Widodo plans to issue a decree on the suspension of issuances of new oil palm plantation development in the country. His decision is a commitment to protect the country’s remaining tropical forests and demonstrate his determination for the country’s environmental stewardship.
- Categories
- Environment
- Region
- South Asia
-
J&J Ebola Vaccine Has Promise as Wider Test Awaits Next Outbreak
An experimental Ebola vaccine from Johnson & Johnson, boosted by a second immunization shot from biotechnology company Bavarian Nordic A/S, generated a powerful immune response among volunteers in its first tests in humans.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Ethiopia Banks on Mobile Money for Financial Growth
Outside a small store on a dirt track in the remote Ethiopian town of Doni, long queues wait for government cash handouts by the most modern of methods: mobile phone.
- Categories
- Technology
- Region
- Sub-Saharan Africa
-
‘India Makes All Mylan HIV Drugs for Developing World’
Rajiv Malik is president of Mylan, the $9.5-billion, Nasdaq-listed global generic and speciality pharmaceuticals company. Malik became part of Mylan in 2007 when the latter acquired India-based Matrix Laboratories, where he was CEO. That deal also transformed Mylan, which till then operated only in the US, into one of the world's largest manufacturers of active pharmaceutical ingredients (APIs). On a recent visit to Bengaluru, Malik spoke to TOI:
- Categories
- Health Care
- Region
- South Asia
-
A Costly Setback for SKS Microfinance?
Just as it seemed SKS Microfinance was getting back on its feet, it has received a body blow once again. It had applied for a small finance bank (SFB) licence, but while eight of the 10 entities the Reserve Bank of India (RBI) awarded these licences to were microfinance institutions (MFIs), SKS Microfinance was not one of them (See Left Out). Indeed, of the 10 leading MFIs in the country, one, Bandhan, has become a full-fledged bank, while another eight will shortly be converted into SFBs. SKS Microfinance is the only one left out.
- Categories
- Uncategorized
- Region
- South Asia
- Tags
- microfinance
-
A New Blood Test for Tuberculosis Could Save Millions of Lives
As much as one third of the global population is currently infected with the bacterium that causes tuberculosis (TB), a disease typically concentrated in the lungs and characterized by weakness, fever, coughing and chest pain. About 9.6 million new infections occurred in 2014, the most recent year for which numbers are available. Roughly 1.5 million people died of TB that same year. The ability to easily, inexpensively and accurately diagnose TB is of utmost importance, but the most commonly used method fails, at least to some extent, on all three counts. A new blood-based technique might considerably rein in this epidemic.
- Categories
- Health Care
- Region
- South Asia
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.